Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

2018279 citationsReviewbronze Open Access

Authors

François‐Clément Bidard · Université de Versailles Saint-Quentin-en-Yvelines

Stefan Michiels · Institut Gustave Roussy

Sabine Riethdorf · University Medical Center Hamburg-Eppendorf

Volkmar Mueller · University Medical Center Hamburg-Eppendorf

Laura J. Esserman

Anthony Lucci · The University of Texas MD Anderson Cancer Center

Bjørn Naume · University of Oslo

Abstract

CTC count is an independent and quantitative prognostic factor in early breast cancer patients treated by NCT. It complements current prognostic models based on tumor characteristics and response to therapy.

Topics & Keywords

Cancer Cells and Metastasis Breast Cancer Treatment Studies Cancer, Stress, Anesthesia, and Immune Response

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JNCI Journal of the National Cancer Institute

Volume 110, Issue 6, pp. 560-567

DOI: 10.1093/jnci/djy018

Field-Weighted Citation Impact: 13.31